Literature DB >> 2859832

Vasodilator therapy for primary pulmonary hypertension.

H I Palevsky, A P Fishman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2859832     DOI: 10.1146/annurev.me.36.020185.003023

Source DB:  PubMed          Journal:  Annu Rev Med        ISSN: 0066-4219            Impact factor:   13.739


× No keyword cloud information.
  5 in total

Review 1.  Nitrates and nitrites in the treatment of ischemic cardiac disease.

Authors:  Vaughn E Nossaman; Bobby D Nossaman; Philip J Kadowitz
Journal:  Cardiol Rev       Date:  2010 Jul-Aug       Impact factor: 2.644

2.  Responses to vasodilator drugs on pulmonary artery preparations from pulmonary hypertensive rats.

Authors:  J C Wanstall; S R O'Donnell
Journal:  Br J Pharmacol       Date:  1992-01       Impact factor: 8.739

3.  Stimulators of soluble guanylyl cyclase: future clinical indications.

Authors:  Bobby D Nossaman; Philip J Kadowitz
Journal:  Ochsner J       Date:  2013

Review 4.  Nitrates for the prevention of cardiac morbidity and mortality in patients undergoing non-cardiac surgery.

Authors:  Na Zhao; Jin Xu; Balwinder Singh; Xuerong Yu; Taixiang Wu; Yuguang Huang
Journal:  Cochrane Database Syst Rev       Date:  2016-08-04

5.  Stimulators and activators of soluble guanylate cyclase: review and potential therapeutic indications.

Authors:  Bobby Nossaman; Edward Pankey; Philip Kadowitz
Journal:  Crit Care Res Pract       Date:  2012-02-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.